ReviewJournal of pharmacy & bioallied sciences
Gut-Immune Interplay: Decoding the Microbiome's Impact on Immunity and Diseases.
Review in Journal of pharmacy & bioallied sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The role of the gut microbiome in antibiotic-driven antimicrobial resistance.Frontiers in microbiology · 2026Review
- The cross-talk between T and B lymphocytes and the oral microbiome in health and disease: a narrative review.Frontiers in immunology · 2026Review
- Aging and vaccines: impact of immunosenescence and inflammaging in vaccine response.Frontiers in aging · 2026Review
- The microbiome-gerogene axis: a new frontier in precision geromedicine.Frontiers in aging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gut microbiome is a critical regulator of local and systemic immunity with downstream consequences on immune functions and health of the host. Coevolution with the host bolsters the development and performance of the immune system, particularly during early life, and also plays roles in immune responses in adulthood. Alterations in the gut microbiome, whether as a result of antibiotics, diet, or environmental manipulation, can also drive inappropriate immune responses and predisposition to infections and inflammatory and autoimmune diseases. Since the microbiome impacts systemic immunity, microbial products stemming from the gut can alter immunity in far-flung tissues. Recent studies have emphasized the therapeutic promise of probiotics due to their ability to modulate gut microbiota and improve immune system activity and symptoms as well as prognosis of different diseases. Aging is one of the key risk factors for several age-related conditions, where the immune system and gut microbiome are major culprits, further explaining the importance of microbiome health across the life course. This emerging approach of microbiome modulation is opening up new pathways for combating infectious diseases, including both antibiotic-resistant infections and viral disease. This review highlights the interdependent nature of the gut microbiome and immune health, with significant ramifications for disease prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.